Clinical Trial Update: Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 study of TRIAPINE in combination with temozolomide for recurrent glioblastoma and recurrent gliomas; currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma
• Glioblastoma
• Low-grade Glioma

Drugs mentioned

• Temozolomide (Temozolomide)
• Triapine (Triapine)

Snippet

Sponsor: Northwestern University | Conditions: Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING